Latin America Molecular Diagnostics Market worth $1.16 billion by 2031
The report "Latin America Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031" is projected to grow from USD 0.76 billion in 2026 and to reach USD 1.16 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 8.8% during the forecast period.
Browse 130 market data Tables and 44 Figures spread through 200 Pages and in-depth TOC on "Latin America Molecular Diagnostics Market by Product & Service (Kits, Instruments), Test Type (Lab, PoC), Sample (Blood, Urine), Technology (PCR, NGS, ISH), Application [Infectious (Hepatitis, HIV, HAI, Flu), Cancer (Breast, Lung)] - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/latin-america-molecular-diagnostics-market-92695433.html
One of the key drivers for the Latin America molecular diagnostics market is the high prevalence of infectious diseases as well as the incidence of cancer, which continues to drive the market for accurate diagnosis. There has been an increased use of molecular diagnostics to support early disease detection and management for various conditions. Moreover, improved accessibility of healthcare resources within the region continues to drive the use of advanced molecular diagnostics technologies.
The reagents & kits segment held the largest share of the Latin America molecular diagnostics market, by product & service, in 2025.
On the basis of product & service, the market is segmented into reagents & kits, instruments, and services & software. In 2025, reagents & kits accounted for the largest share, supported by their recurring use in every molecular diagnostic test performed. High testing volumes across infectious diseases & oncology, along with expanding availability of assay kits tailored to regional disease profiles, resulted in consistent demand. Additionally, the need for regular replenishment of consumables and the ongoing introduction of new assay formats contribute to the segment’s dominant market position.
The screening segment is expected to be the fastest-growing segment, by clinical application, during the forecast period.
Based on clinical application, the market is segmented into diagnostics and screening. Among these, the screening segment is expected to witness the fastest growth rate, driven by increasing emphasis on early disease identification and preventive healthcare. The wider adoption of molecular screening programs and growing awareness of the benefits of early detection are supporting the faster expansion of this segment across Latin America.
The major players operating in this market are Danaher (US), F. Hoffmann-La Roche Ltd. (Switzerland), Illumina, Inc. (US), bioMérieux (France), Thermo Fisher Scientific Inc. (US), Hologic, Inc. (US), Abbott (US), Siemens Healthineers AG (Germany), QIAGEN (Netherlands), and Becton, Dickinson and Company (US).
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com/
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
- What are the Known and Unknown Adjacencies Impacting the Latin America Molecular Diagnostics Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
